Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |